Skip to content

Effect of dexmedetomidine combined with cytokine adsorption technique on perioperative cognitive function in patients undergoing cardiac surgery

Effect of dexmedetomidine combined with cytokine adsorption technique on perioperative cognitive function in patients undergoing cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079255
Enrollment
Unknown
Registered
2023-12-28
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac surgery

Interventions

Group A:Cytokine adsorption techniques were used during intraoperative and postoperative dexmedetomidine pumping combined with extracorporeal circulation.
Group B:Intraoperative and postoperative dexmedetomidine pumping combined with standard extracorporeal circulation.
Group C:Cytokine adsorption techniques were used during intraoperative and postoperative pumping of 0.9% Saline combined with extracorporeal circulation.
Group D:Intraoperative and postoperative pumping of 0.9% Saline combined with standard extracorporeal circulation.

Sponsors

The First Affiliated hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adult patients (age =18 years) who were scheduled to undergo extracorporeal cardiac surgery under general anaesthesia, including coronary artery bypass grafting, valve surgery, or combined coronary artery bypass graft valve replacement, were included in this study.

Exclusion criteria

Exclusion criteria: Patients meeting any of the following criteria would be excluded: (1) refusal to provide written informed consent; (2) preoperative history of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, or severe dementia; (3) inability to communicate due to visual, hearing, speech, or other impairments; (4) history of brain injury or neurosurgery; (5) left ventricular ejection fraction <30%; (6) history of morbid sinus node syndrome, history of severe bradycardia (heart rate <50 beats per minute), or =2 degrees of atrioventricular block; (7) severe hepatic failure (Child-Pugh class C); (8) severe renal failure (requiring renal replacement therapy); and (9) patients with allergies to experimental medications and to haemoperfusion devices, filters, and anticoagulants.

Design outcomes

Primary

MeasureTime frame
Incidence of perioperative cognitive dysfunction;

Secondary

MeasureTime frame
Perioperative changes in cognitive function;Inflammatory factor levels;Brain injury marker levels;

Countries

China

Contacts

Public ContactCheng Hu

The First Affiliated hospital of Xinjiang Medical University

531949546@qq.com+86 159 0900 2658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026